Do glucagon-like peptide-1 receptor (GLP-1R) agonists have potential as adjuncts in the treatment of type 1 diabetes?

MLA

Sheila A Doggrell. “Do Glucagon-like Peptide-1 Receptor (GLP-1R) Agonists Have Potential as Adjuncts in the Treatment of Type 1 Diabetes?” Expert Opinion on Pharmacotherapy, vol. 19, no. 15, Sept. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6fdc1085764f86e3d355baf0f19fb2cf&authtype=sso&custid=ns315887.

APA

Sheila A Doggrell. (2018). Do glucagon-like peptide-1 receptor (GLP-1R) agonists have potential as adjuncts in the treatment of type 1 diabetes? Expert Opinion on Pharmacotherapy, 19(15).

Chicago

Sheila A Doggrell. 2018. “Do Glucagon-like Peptide-1 Receptor (GLP-1R) Agonists Have Potential as Adjuncts in the Treatment of Type 1 Diabetes?” Expert Opinion on Pharmacotherapy 19 (15). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6fdc1085764f86e3d355baf0f19fb2cf&authtype=sso&custid=ns315887.